Lee Johnson Capital Management LLC Invests $2.27 Million in CME Group Inc. $CME

Lee Johnson Capital Management LLC purchased a new position in CME Group Inc. (NASDAQ:CMEFree Report) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 8,406 shares of the financial services provider’s stock, valued at approximately $2,271,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Vanguard Group Inc. increased its position in CME Group by 1.5% in the second quarter. Vanguard Group Inc. now owns 35,176,376 shares of the financial services provider’s stock worth $9,695,313,000 after buying an additional 532,549 shares during the last quarter. Geode Capital Management LLC increased its holdings in CME Group by 3.6% in the 2nd quarter. Geode Capital Management LLC now owns 9,178,681 shares of the financial services provider’s stock worth $2,524,271,000 after acquiring an additional 319,899 shares during the last quarter. Norges Bank bought a new stake in CME Group in the 2nd quarter valued at about $1,571,447,000. Ameriprise Financial Inc. lifted its holdings in CME Group by 2.0% during the second quarter. Ameriprise Financial Inc. now owns 4,682,066 shares of the financial services provider’s stock valued at $1,289,910,000 after purchasing an additional 92,925 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership lifted its holdings in CME Group by 6.6% during the second quarter. Arrowstreet Capital Limited Partnership now owns 3,833,090 shares of the financial services provider’s stock valued at $1,056,476,000 after purchasing an additional 238,522 shares during the last quarter. 87.75% of the stock is owned by institutional investors.

CME Group Price Performance

CME opened at $275.83 on Wednesday. The stock has a market capitalization of $99.46 billion, a P/E ratio of 26.73, a PEG ratio of 3.75 and a beta of 0.28. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group Inc. has a 12-month low of $224.62 and a 12-month high of $290.79. The stock has a 50-day moving average price of $273.50 and a 200-day moving average price of $272.00.

CME Group (NASDAQ:CMEGet Free Report) last released its earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share for the quarter, topping analysts’ consensus estimates of $2.63 by $0.05. The company had revenue of $1.54 billion during the quarter, compared to the consensus estimate of $1.56 billion. CME Group had a return on equity of 14.61% and a net margin of 58.84%.CME Group’s quarterly revenue was down 3.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.68 EPS. Equities analysts predict that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 30th. Investors of record on Friday, December 12th were issued a dividend of $1.25 per share. The ex-dividend date of this dividend was Friday, December 12th. This represents a $5.00 annualized dividend and a dividend yield of 1.8%. CME Group’s dividend payout ratio (DPR) is currently 48.45%.

Key Headlines Impacting CME Group

Here are the key news stories impacting CME Group this week:

Analysts Set New Price Targets

CME has been the subject of several recent research reports. Rothschild & Co Redburn lifted their target price on shares of CME Group from $297.00 to $300.00 and gave the stock a “neutral” rating in a research note on Thursday, November 6th. Raymond James Financial decreased their price target on shares of CME Group from $309.00 to $307.00 and set an “outperform” rating on the stock in a report on Monday, October 13th. Citigroup raised CME Group from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $275.00 to $300.00 in a research note on Thursday, September 25th. Piper Sandler boosted their target price on CME Group from $296.00 to $313.00 and gave the stock an “overweight” rating in a research report on Thursday, November 13th. Finally, Keefe, Bruyette & Woods raised their price target on CME Group from $283.00 to $287.00 and gave the company a “market perform” rating in a report on Monday, October 13th. Eight equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $290.82.

Check Out Our Latest Research Report on CME

Insider Activity

In other CME Group news, CEO Terrence A. Duffy sold 25,000 shares of the stock in a transaction that occurred on Thursday, December 11th. The stock was sold at an average price of $269.55, for a total value of $6,738,750.00. Following the completion of the sale, the chief executive officer owned 65,804 shares in the company, valued at approximately $17,737,468.20. This trade represents a 27.53% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Harold Eugene Jr. Ford sold 1,000 shares of the business’s stock in a transaction that occurred on Monday, November 3rd. The shares were sold at an average price of $263.53, for a total value of $263,530.00. Following the transaction, the director directly owned 1,091 shares in the company, valued at $287,511.23. This trade represents a 47.82% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.30% of the stock is currently owned by insiders.

CME Group Profile

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

Further Reading

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.